No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
VKTX241227P49000
- 6.90
- -4.00-36.70%
15min DelayClose Dec 20 16:00 ET
6.90High6.90Low
6.90Open10.90Pre Close1 Volume13 Open Interest49.00Strike Price690.00Turnover182.22%IV0.36%PremiumDec 27, 2024Expiry Date6.75Intrinsic Value100Multiplier4DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.7376Delta0.0385Gamma5.31Leverage Ratio-0.3157Theta-0.0043Rho-3.92Eff Leverage0.0152Vega
Intraday
- 5D
- Daily
News
Why Viking Therapeutics Tumbled by More Than 10% This Week
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla -- WSJ
B.Riley Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $109
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)